bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Stoke Therapeutics Inc. logo

    Stoke Therapeutics Inc.

    STOK | NASDAQ
    Chart Builder DCF Calculator
    $28.64
    +$0.59 (+2.10%)
    Sep 22, 2026, 10:40 AM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $1.81B
    Enterprise Value
    $1.52B
    Beta
    1.23
    Average Volume
    778.81K
    Shares Outstanding (Diluted)
    66.02M
    Shares Change YoY
    13.13%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US86150R1077

    Price Performance

    Price Change 1M
    -13.1%
    Price Change 3M
    -9.8%
    Price Change 6M
    -17.0%
    Price Change YTD
    -9.2%
    Price Change 1Y
    22.8%
    Price Change 3Y
    571.0%
    Price Change 5Y
    7.9%
    1M CAGR (ann.)
    -14.3%
    1Y CAGR (ann.)
    19.4%
    5Y CAGR (ann.)
    2.0%
    All-Time CAGR
    1.3%

    Valuation

    PE Ratio
    -8.35
    Forward PE
    N/A
    PEG Ratio
    -0.06
    Forward PEG
    3.79
    PS Ratio
    65.61
    Forward PS
    40.40
    PB Ratio
    5.24
    P/FCF Ratio
    -10.02
    P/Adj. FCF Ratio
    -8.62
    P/OCF Ratio
    -10.39
    EV/Sales
    55.09
    EV/EBIT
    -7.25
    EV/EBITDA
    -7.40
    EV/FCF
    -8.41
    Earnings Yield
    -12.0%
    FCF Yield
    -10.0%
    Adj. FCF Yield
    -11.6%

    Financial Health

    Net Cash
    $290.97M
    Total Debt
    $2.68M
    Cash & Short-Term Investments
    $292.82M
    Total Assets
    $393.97M
    Current Ratio
    7.69
    Quick Ratio
    7.69
    Debt / Equity Ratio
    0.01
    Debt / EBITDA
    -0.01
    Debt / FCF
    -0.01
    OCF / Debt
    -66.36
    Interest Coverage
    -4,856.02
    Altman Z-Score
    19.43
    Piotroski F-Score
    2

    Margins & Profitability

    Gross Profit Margin
    84.7%
    Operating Profit Margin
    -809.7%
    EBITDA Margin
    -744.4%
    Net Profit Margin
    -753.6%
    FCF Margin
    -654.9%
    Adj. FCF Margin
    -761.5%
    SBC / Revenue
    106.6%
    SBC Impact (per share)
    -16.3%

    Returns

    Return on Assets
    -52.8%
    Return on Equity
    -59.4%
    Return on Invested Capital
    -62.7%
    Return on Capital Employed
    -63.5%
    Return on Tangible Assets
    -52.8%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    46.1%
    Revenue CAGR 5Y
    45.4%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    -37.7%
    EPS CAGR 5Y
    7.6%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -75.0%
    FCF CAGR 5Y
    -27.0%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    16
    EPS Growth Next 3Y
    32.1%
    Revenue Growth Next 3Y
    135.0%
    Earnings Date
    Nov 2, 2026
    EPS Estimate (next Q)
    -$0.88
    EPS Growth Est (next Q)
    35.4%
    Revenue Est (next Q)
    $8.21M
    Revenue Growth Est (next Q)
    -22.8%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $51
    Price Target Upside
    81.8%

    Cash Flow

    Operating Cash Flow
    $-177.99M
    Free Cash Flow
    $-180.68M
    Adj. Free Cash Flow
    $-210.08M
    FCF Per Share
    -$2.74
    OCF Per Share
    -$2.70
    OCF/S Ratio
    -645.2%

    Income Statement

    Revenue
    $27.59M
    Gross Profit
    $23.36M
    Operating Income
    $-223.38M
    EBITDA
    $-205.36M
    Net Income
    $-207.9M
    EPS (Diluted)
    -$3.36
    Revenue / Employee
    $162.28K
    Profit / Employee
    $-1.22M
    Employees
    170

    © 2026 bestshares.com. All rights reserved.